Menu
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.

Julg B, Tartaglia LJ, Keele BF, Wagh K, Pegu A, Sok D, Abbink P, Schmidt SD, Wang K, Chen X, Joyce MG, Georgiev IS, Choe M, Kwong PD, Doria-Rose NA, Le K, Louder MK, Bailer RT, Moore PL, Korber B, Seaman MS, Abool Karim SS, Morris L, Koup RA, Mascola JR, Burton DR, Barouch DH.
Science Translational Medicine 2017; 9(406): eaal1321. DOI: 10.1126/scitranslmed.aal1321

Read publication
Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing.

Kufa T, Kharsany A, Cawood C, Khanyile D, Lewis L, Grobler A, Chipeta Z, Bere A, Glenshaw M, Puren A.
Journal of the International AIDS Society 2017; 20(Suppl 6):35-43.

Read publication
CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.

Vandormael A, Rego F, Danaviah S, Carlos Junior Alcantara L, Boulware DR, de Oliveira T.
Current HIV Research 2017; 15(3):225-231.

Read publication
Research Ethics Governance in Times of Ebola

Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sheel S, Segelid MJ, Ahmad A, Dawson A, Singh J, Jesani A, Upshur R. .
Public Health Ethics 2017; 10(1):49-61.

Read publication
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.

Naicker N, Naidoo A, Werner L, Garrett N, Majola N, Asari V, Baxter C, Grobler A, Abdool Karim Q, Abdool Karim SS.
Antiviral Therapy 2017; 22(4):287-293.

Read publication
Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention.

Liebenberg L, Archary D, Sivro A, Kwon DS.
Genome Medicine 2017; 9(1):74. DOI 10.1186/s13073-017-0469-2

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.